ACTIVE

APOTHEEK BINNENHOF

Financial year 2025 · Closed on 31/12/2025

Net result70,5 k €+249,9 %over 1 year
Gross margin189,2 k €+40,2 %over 1 year
Equity86,6 k €+98,7 %over 1 year
Workforce1,2 ETP-20,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK BINNENHOF is a Private limited company incorporated in 2018. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Tessenderlo-Ham. It employs on average 1,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0699.578.351
Incorporation
03/07/2018
Legal form
Private limited company
Registered office
Binnenhof 14
3980 Tessenderlo-Ham · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
1,2 ETP
Joint committees (1)
  • 313
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 8 filings

Trend over 8 financial years

20252024202320222021
Income statement
Gross margin189,2 k €135 k €125,5 k €124,2 k €215,4 k €
EBITDA119,3 k €-7,2 k €35,1 k €77 k €193,7 k €
Operating result94,2 k €-30,3 k €15 k €58,2 k €168,1 k €
Net result70,5 k €-47 k €5,5 k €52,9 k €117,6 k €
Balance sheet
Equity86,6 k €43,6 k €205,6 k €200,1 k €192,7 k €
Total assets754,2 k €744,3 k €496,2 k €622,8 k €578,1 k €
Cash73 k €71,8 k €97,5 k €72 k €–
Debts641,6 k €700,7 k €287,8 k €347,7 k €384,3 k €
Other
Workforce1,2 ETP1,5 ETP1,5 ETP1,1 ETP0,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 6 ended

Active mandates

ARKLIN

Director · since 01 janvier 2023 · 0787.351.671

Represented by Arkesteyn Inge

Active
DYSS

Director · since 01 juin 2022 · 0635.840.641

Represented by Dassen Yves

Active

Ended mandates

ARKLIN

Director · since 01 janvier 2023 · 0787.351.671

Represented by Arkesteyn INGE

Ended
DYSS

Director · since 01 juin 2022 · 0635.840.641

Represented by Dassen YVES

Ended
Nadine Jonkers

Manager · since 27 juin 2018

Ended
APOTHEEK BINNENHOF

Director · 0699.578.351

Represented by Inge Arkesteyn

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/07/202627/08/202528/08/202430/08/202329/07/202228/07/2021
General meeting30/06/202620/06/202521/06/202416/06/202331/05/202218/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202623/07/2026DutchPDF
Abridged model31/12/202420/06/202527/08/2025DutchPDF
Abridged model31/12/202321/06/202428/08/2024DutchPDF
Abridged model31/12/202216/06/202330/08/2023DutchPDF
Abridged model31/12/202131/05/202229/07/2022DutchPDF
Abridged model31/12/202018/06/202128/07/2021DutchPDF
Micro model31/12/201919/06/202030/07/2020DutchPDF
Abridged model31/12/201831/07/201931/08/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 6 ended

Active mandates

ARKLIN

Director · since 01 janvier 2023 · 0787.351.671

Represented by Arkesteyn Inge

Active
DYSS

Director · since 01 juin 2022 · 0635.840.641

Represented by Dassen Yves

Active

Ended mandates

ARKLIN

Director · since 01 janvier 2023 · 0787.351.671

Represented by Arkesteyn INGE

Ended
DYSS

Director · since 01 juin 2022 · 0635.840.641

Represented by Dassen YVES

Ended
Nadine Jonkers

Manager · since 27 juin 2018

Ended
APOTHEEK BINNENHOF

Director · 0699.578.351

Represented by Inge Arkesteyn

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates16/10/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/03/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/08/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other06/11/2018
    DIVERSEN
    PDF
  • Other05/07/2018
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202570,5 k €↑
  2. 2024
    Annual accounts 2024-47 k €↓
  3. 2023
    Annual accounts 20235,5 k €↓
  4. 2022
    Annual accounts 202252,9 k €↓
  5. 2022
    Name changeAPOTHEEK BINNENHOF
  6. 2021
    Annual accounts 2021117,6 k €↑
  7. 2021
    Name changeBinnenhof Apotheek
  8. 2020
    Annual accounts 2020406,9 €↓
  9. 2019
    Annual accounts 201927,4 k €↓
  10. 2018
    Annual accounts 201834,9 k €
  11. 03/07/2018
    IncorporationPrivate limited company